gift of more than $5.75 million from anonymous donors will allow the UVA Cancer Center to speed the development of new treatments for rare blood cancers and provide more patients with access to cutting-edge clinical trials.
The gift will fund an initiative, with several projects already in the pipeline, that will help doctors better understand and treat rare blood cancers. Because these cancers are uncommon, doctors and scientists often struggle to obtain funding for potentially life-saving research.
“Individually, these cancers affect relatively small numbers of people when compared with other cancers, but collectively, they touch the lives of countless patients and families,” said Dr. K. Craig Kent, chief executive officer of UVA Health and executive vice president for health affairs at the University of Virginia. “We are deeply grateful for this generous gift that will allow us to conduct important, groundbreaking cancer research and develop new treatments that will benefit patients around the world.”
Reference Link: https://news.virginia.
